Literature DB >> 19283684

A novel COL1A1 gene-splicing mutation (c.1875+1G>C) in a Brazilian patient with osteogenesis imperfecta.

C Barbirato1, M G Almeida, M Milanez, V Sipolatti, M R G O Rebouças, A N Akel, V R R Nunes, A M S Perrone, M Zatz, I D Louro, F Paula.   

Abstract

Osteogenesis imperfecta is a heterogeneous genetic disorder characterized by bone fragility and deformity, recurrent fractures, blue sclera, short stature, and dentinogenesis imperfecta. Most cases are caused by mutations in COL1A1 and COL1A2 genes. We present a novel splicing mutation in the COL1A1 gene (c.1875+1G>C) in a 16-year-old Brazilian boy diagnosed as a type III osteogenesis imperfecta patient. This splicing mutation and its association with clinical phenotypes will be submitted to the reference database of COL1A1 mutations, which has no other description of this mutation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19283684     DOI: 10.4238/vol8-1gmr563

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  2 in total

1.  Ocular characteristics and complications in patients with osteogenesis imperfecta: a systematic review.

Authors:  Sanne Treurniet; Pia Burger; Ebba A E Ghyczy; Frank D Verbraak; Katie R Curro-Tafili; Dimitra Micha; Nathalie Bravenboer; Stuart H Ralston; Ralph de Vries; Annette C Moll; Elisabeth Marelise W Eekhoff
Journal:  Acta Ophthalmol       Date:  2021-05-19       Impact factor: 3.988

2.  Osteogenesis imperfecta in Brazilian patients.

Authors:  Maira Trancozo; Marcos V D Moraes; Dalila A Silva; Jéssica A M Soares; Clara Barbirato; Márcio G Almeida; Lígia R Santos; Maria R G O Rebouças; Akel N Akel; Valentim Sipolatti; Vanda R R Nunes; Flavia I V Errera; Meire Aguena; Maria R Passos-Bueno; Flavia de Paula
Journal:  Genet Mol Biol       Date:  2019-08-15       Impact factor: 1.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.